Skip to Content

Janus Henderson Global Life Sciences C JFNCX

Medalist Rating as of | See Janus Henderson Investment Hub
  • NAV / 1-Day Return 58.32  /  0.43 %
  • Total Assets 4.8 Bil
  • Adj. Expense Ratio
    1.760%
  • Expense Ratio 1.760%
  • Distribution Fee Level Low
  • Share Class Type Level Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield
  • Turnover 21%

Morningstar’s Analysis JFNCX

Will JFNCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Janus Henderson Global Life Sciences C's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings JFNCX

  • Current Portfolio Date
  • Equity Holdings 101
  • Bond Holdings 0
  • Other Holdings 26
  • % Assets in Top 10 Holdings 31.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
6.05
295,799,314
Healthcare
4.18
204,196,357
Healthcare
3.63
177,455,466
Healthcare
2.89
141,206,631
Healthcare
2.89
141,161,895
Healthcare
2.69
131,360,924
Healthcare
2.37
115,699,106
Healthcare
2.36
115,187,470
Healthcare
2.28
111,464,832
Healthcare
2.27
111,075,976
Healthcare